Shionogi & Co., Ltd. (OTCMKTS:SGIOF) Sees Significant Drop in Short Interest

Shionogi & Co., Ltd. (OTCMKTS:SGIOFGet Free Report) was the recipient of a significant decrease in short interest in February. As of February 28th, there was short interest totalling 2,662,200 shares, a decrease of 13.1% from the February 13th total of 3,064,000 shares. Based on an average trading volume of 100 shares, the days-to-cover ratio is presently 26,622.0 days.

Shionogi & Co., Ltd. Stock Performance

OTCMKTS:SGIOF remained flat at $13.45 during trading hours on Wednesday. The company’s stock had a trading volume of 1 shares, compared to its average volume of 260. The company has a 50-day moving average price of $13.93 and a 200-day moving average price of $18.15. Shionogi & Co., Ltd. has a 1 year low of $12.21 and a 1 year high of $16.53.

Shionogi & Co., Ltd. Company Profile

(Get Free Report)

Shionogi & Co, Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan. It offers Fetroja, a multidrug-resistant for gram-negative bacterial infection treatment; Cabenuva and Apretude an anti-HIV and HIV prophylactic drug; Xocova an oral COVID-19 treatment drug; Finibax a carbapenem antibiotic; Xofluza, an influenza antiviral drug; and Tivicay, an anti-HIV drug.

Featured Articles

Receive News & Ratings for Shionogi & Co. Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shionogi & Co. Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.